Lv7
4980 积分 2022-11-06 加入
Phase I/II Study of Tifcemalimab, an Anti–B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer
1个月前
已完结
PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes
3个月前
已完结
Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase–Deficient Renal Cell Carcinoma
5个月前
已关闭
Muscle-Invasive Bladder Cancer: A Watershed Moment
9个月前
已完结
皖公网安备34019202002308
